Like the Escalade IQ, the 2026 Vistiq has a swept-back windshield and a Black Crystal Shield grille. Black Crystal Shield patterns are featured on Luxury and Sport trims. The exterior also features ...

Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot causes excessive bone mineral ...

Cybersecurity giant CrowdStrike on Wednesday announced plans to acquire Israel-based SaaS security company Adaptive Shield. Adaptive Shield provides comprehensive SaaS security posture management, ...

The tank is layered with Viking shields, inspired by the series ... the Spawn of Jormungandr style showcases the intricate decorative patterns found on weapons seen in the Vikings, embodying ...

SAN AN­TO­NIO — Promis­ing da­ta don’t al­ways equal a stock pop. Viking Ther­a­peu­tics pre­sent­ed what an­a­lysts thought were com­pelling da­ta on an oral … ...

Taylor Hill/Getty; Pascal Le Segretain/Getty Brooke Shields is weighing in on John Mulaney's latest photo shoot. The model and actress, 59, took a moment to shout out the comedian for recreating ...

Nov 4 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab shares reversed course to fall 8% on Monday as focus shifted to the drug developer's ability to mass produce its oral obesity ...

It sure was a spooky day to get an MRI scan. But for patients who visited Shields Health in Dedham on Halloween, the trip was less frightening than normal. The Quincy-based company’s adoption of ...

Getty Images Viking Therapeutics shares fell Monday after reporting the latest results from trials of its weight-loss drugs. Analysts say the treatment, which is being tested in both oral and ...

Viking Therapeutics is rowing its longboat toward the front of the oral obesity therapy race, posting detailed phase 1 data that suggest its dual agonist of GLP-1 and GIP can hold its own in a ...

SAN AN­TO­NIO — Viking Ther­a­peu­tics’ high­ly an­tic­i­pat­ed read­out of its oral an­ti-obe­si­ty pill showed a place­bo-ad­just­ed weight loss of 6.8% af­ter four weeks ...